
Hair loss during perimenopause and menopause can feel deeply personal. If you’ve noticed more strands in the shower, a widening part, or less volume than you once had, you are not alone. In fact, up to 50% of women experience hair thinning at some point in midlife.
At NiuOla Health in Olympia, Washington, we want you to know something important:
Hair loss during perimenopause and menopause is common, medically understood, and treatable.
This guide will walk you through why hormonal shifts affect your hair, what other factors may contribute, and the evidence-based treatments that truly make a difference.
Hair follicles are highly sensitive to hormonal changes. During perimenopause, estrogen levels begin to decline while the relative influence of androgens (hormones women also naturally produce) increases.
Estrogen helps keep hair in the anagen (growth) phase longer. When estrogen drops:
Over time, this leads to female pattern hair loss, which typically appears as thinning at the crown or widening of the part while the hairline stays intact.
Hormones are the primary driver, but they’re rarely acting alone.
At our Olympia clinic, we always start with a thorough medical evaluation because many contributing factors are treatable.
High cortisol levels can push hair into the shedding phase. Hair loss often appears 2–3 months after a stressful event.
Common and correctable contributors include:
Research published in dermatology literature supports evaluating ferritin and vitamin D levels in women with diffuse hair thinning.
Both hypothyroidism and hyperthyroidism can cause diffuse hair loss. Thyroid dysfunction becomes more common in midlife and should always be ruled out with blood work.
Sleep disturbances, very common in perimenopause, impact hormonal balance and cellular repair, affecting hair health over time.
When it comes to treating female pattern hair loss, minoxidil is the gold standard and the only FDA-approved medication specifically indicated for women.
A temporary increase in shedding during the first few weeks is normal. It often means the follicles are transitioning into a healthier growth cycle.
For women who prefer not to use topical medication, low-dose oral minoxidil (0.25–2.5 mg daily) is increasingly prescribed.
Potential side effects may include:
At NiuOla Health, we carefully evaluate whether oral therapy is appropriate based on your medical history.
When androgen sensitivity plays a larger role, additional medications may help.
Originally a blood pressure medication, spironolactone blocks androgen receptors in hair follicles.
These medications reduce conversion of testosterone to DHT (the hormone responsible for follicle miniaturization). They are typically reserved for postmenopausal women.
Hormone-based treatments are not first-line for everyone but may be appropriate depending on your clinical picture.
These treatments can enhance results when combined with medical therapy.
Red light devices stimulate follicle metabolism. Studies show modest but meaningful improvement with consistent use 3–4 times weekly.
PRP uses your own growth factors injected into the scalp to stimulate dormant follicles. Typically done as a series of treatments.
Creates controlled micro-injuries to stimulate growth factors and enhance absorption of topical treatments. Research suggests improved outcomes when combined with minoxidil.
Before starting supplements, testing is essential.
Deficiency is common in midlife women in Washington due to limited sun exposure.
Supports protein synthesis and follicle structure.
Support overall cellular metabolism.
Always test before supplementing. A personalized plan is more effective than a generic “hair supplement.”
Hormone replacement therapy is not a primary treatment for hair loss during perimenopause. However:
If you’re already considering HRT for hot flashes, sleep disruption, or mood changes, hair stabilization may be a secondary benefit.
At NiuOla Health in Olympia, we provide individualized menopause care and help you weigh the full picture.
Hair treatment requires patience.
Possible initial shedding
Early regrowth begins
Visible density improvement
Maximum benefit and maintenance
Stopping treatment typically results in gradual return of shedding.
Consistency matters more than perfection.

If you’re experiencing hair loss during perimenopause or menopause, here’s how we approach care:
Topical or oral minoxidil is usually the foundation.
Consider spironolactone, PRP, microneedling, or light therapy if appropriate.
Take photos every 3 months in consistent lighting.
Hair loss during perimenopause and menopause is common. It is not a personal failure. It is not vanity to care about it. And most importantly:
At NiuOla Health, our direct primary care clinic in Olympia, Washington, we take time to understand the whole picture: your hormones, nutrition, stress levels, sleep, and overall health. We build a plan that feels sustainable and empowering.
If you’re ready to address hair loss with evidence-based, compassionate care:
We’re here to support you through every stage of life, with clarity, compassion, and science-backed solutions.